JHS Svendgaard Laboratories Limited (JHS) AI Stock Analysis

• Market Cap: ₹679.14M
• Dividend Yield: N/A
• Average Volume (3M): 16.78K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.05
• Revenue Growth: 10.54%
• EPS Growth: 90.30%
• Country: IN
• Employees: 250
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.95
• Shares Outstanding: 87,405,770
• 10 Day Avg. Volume: 16,348
• 30 Day Avg. Volume: 16,781
• PEG Ratio: 0.33
• Price to Book (P/B): 0.33
• Price to Sales (P/S): 0.56
• P/FCF Ratio: -3.84
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: ₹7.50 ▼(-19.70% Downside)
• Action: Reiterated
• Date: 06/09/26

Positive Factors

Low Leverage / Balance Sheet Strength

Low leverage and a stable asset/equity base give the company durable solvency flexibility, reducing default and refinancing risk. Over 2–6 months this balance-sheet strength supports continued operations, potential opportunistic investment, and resilience against cyclical revenue swings.

Negative Factors

Ongoing Net Losses

Persistent operating losses erode retained earnings and limit internal funding for growth or product investment. Over months, continued negative margins constrain strategic flexibility, elevate dependence on cash reserves or financing, and make it harder to convert balance-sheet strength into shareholder returns.

JHS Svendgaard Laboratories Limited Business Overview & Revenue Model

Company Description

JHS Svendgaard Laboratories Limited, along with its associated companies, specializes in the manufacturing and sale of a diverse array of oral and dental hygiene products, catering to both adults and children throughout India. Their extensive prod...

Read more

JHS Svendgaard Laboratories Limited, along with its associated companies, specializes in the manufacturing and sale of a diverse array of oral and dental hygiene products, catering to both adults and children throughout India. Their extensive prod...

How the Company Makes Money

JHS makes money primarily through the sale of finished goods in oral care and personal care categories and through manufacturing services for third parties. Key revenue streams typically include: (1) branded product sales, where JHS sells its own ...

Read more

JHS makes money primarily through the sale of finished goods in oral care and personal care categories and through manufacturing services for third parties. Key revenue streams typically include: (1) branded product sales, where JHS sells its own ...

JHS Svendgaard Laboratories Limited Financial Statement Overview

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	935.64M	1.02B	919.97M	698.06M	840.82M	854.91M
Gross Profit	329.55M	177.22M	309.55M	203.55M	165.45M	201.68M
EBITDA	-15.86M	26.15M	-39.92M	33.78M	-163.82M	85.45M
Net Income	-79.38M	-19.22M	-197.44M	-40.58M	-175.17M	-40.52M
Balance Sheet
Total Assets	2.07B	2.15B	2.01B	1.97B	2.28B	2.22B
Cash, Cash Equivalents and Short-Term Investments	200.11M	205.09M	200.16M	94.56M	386.51M	80.19M
Total Debt	105.87M	148.51M	64.58M	51.29M	155.09M	61.82M
Total Liabilities	332.52M	405.49M	284.41M	271.70M	543.87M	269.46M
Stockholders Equity	1.74B	1.75B	1.73B	1.70B	1.74B	1.86B
Cash Flow
Free Cash Flow	-29.85M	-148.91M	-157.11M	-401.17M	89.43M	-158.75M
Operating Cash Flow	-29.85M	-20.97M	-51.78M	-85.84M	232.86M	-91.36M
Investing Cash Flow	92.77M	-130.38M	-220.18M	-217.34M	96.77M	-46.97M
Financing Cash Flow	38.02M	121.43M	232.97M	21.74M	-9.00M	-16.72M

JHS Svendgaard Laboratories Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 9.34
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JHS, the sentiment is Negative. The current price of 9.34 is above the 20-day moving average (MA) of 8.23, above the 50-day MA of 8.66, and below the 200-day MA of 10.03, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 37.74 is Neutral, neither overbought nor oversold. The STOCH value of 22.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JHS.

JHS Svendgaard Laboratories Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COLPAL	76 Outperform	₹541.93B	40.84	―	2.42%	-0.08%	-7.76%
DABUR	75 Outperform	₹751.89B	39.62	―	1.62%	5.01%	7.14%
EMAMILTD	69 Neutral	₹174.34B	22.31	―	1.91%	-0.78%	-3.87%
HONASA	64 Neutral	₹136.18B	67.80	―	―	15.72%	174.63%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GODREJCP	59 Neutral	₹1.06T	56.93	―	1.67%	7.81%	0.51%
JHS	44 Neutral	₹679.14M	-33.48	―	―	10.54%	90.30%